Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Plan - Growth
Category: Index Fund
Launch Date: 26-10-2020
AUM:
195.49 Cr
Expense Ratio
1.08%
Benchmark
MSCI ACWI TRI
ISIN
INF754K01LR3
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
100
Fund Manager
Mr. Bhavesh Jain, Ms. Manasi Jalgaonkar & Mr. Amit Vora
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Plan - Growth | 20.98 | 18.89 | 13.38 |
| MSCI ACWI TRI | 32.81 | 24.87 | 15.16 |
If you invested in this fund:
₹
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
23.8387
Last change
-0.12 (-0.4983%)
Fund Size (AUM)
₹ 195.49 Cr
Performance
16.22% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The Scheme will invest in stocks comprising of the MSCI India Domestic IMI and World Healthcare Select Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Fund Manager
Mr. Bhavesh Jain, Ms. Manasi Jalgaonkar & Mr. Amit Vora
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.96 |
| Eli Lilly & Co | 6.85 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.71 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.21 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.14 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.84 |
| Dr. Reddys Laboratories Ltd | 4.44 |
| JOHNSON & JOHNSON | 4.35 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.62 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.48 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 69.3 |